Omega-3-acid ethyl esters type a - Generic Drug Details
What are the generic drug sources for omega-3-acid ethyl esters type a and what is the scope of freedom to operate?
Omega-3-acid ethyl esters type a
is the generic ingredient in one branded drug marketed by Osmotica Pharm Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for omega-3-acid ethyl esters type a
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 79 |
| DailyMed Link: | omega-3-acid ethyl esters type a at DailyMed |
Recent Clinical Trials for omega-3-acid ethyl esters type a
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | PHASE1 |
| University of Missouri-Columbia | PHASE2 |
| Washington University School of Medicine | PHASE2 |
US Patents and Regulatory Information for omega-3-acid ethyl esters type a
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm Us | OMTRYG | omega-3-acid ethyl esters type a | CAPSULE;ORAL | 204977-001 | Apr 23, 2014 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
